Alimera Sciences Inc - Company Profile
Powered by 
All the data and insights you need on Alimera Sciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Alimera Sciences Inc Strategy Report
- Understand Alimera Sciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Alimera Sciences Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 18 May 2023 | Alimera Sciences Enters into Licensing Agreement with EyePoint Pharma | Licensing Agreement |
Alimera Sciences Inc
|
EyePoint Pharmaceuticals Inc |
| 18 May 2023 | Alimera Sciences Raises USD69 Million in Private Placement of Shares | Equity Offering |
Caligan Partners LP
Velan Ventures, Inc.
|
Alimera Sciences Inc |
| 24 Mar 2023 | Alimera Sciences Raises USD12 Million in Private Placement | Equity Offering | - |
Alimera Sciences Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer